Internal Medicine, Endocrinology, Diabetes, & Metabolism · Saint Paul, MN
NPI
1972557908
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
255 Smith Ave N, Suite 100
Saint Paul, MN, 55102
Phone (651) 241-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$190K
9,933 services
Medicare patients, 2024
791
Average age 72
Drug cost, 2024
$3.2M
6,659 prescriptions
Company payments, 2025
$25.36
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luke E Benedict was code J0897 (injection, denosumab, 1 mg), 3,120 times for 32 patients. In total Luke E Benedict billed 9,933 services in 142 codes, and Medicare paid $190K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,120 | 32 | $19.92 | $62K |
| 36415 Venipuncture Blood Collection | Office | 433 | 350 | $8.61 | $3,728 |
| 99214 Office E&M - Established | Office | 360 | 224 | $90.64 | $33K |
| 95251 Test - Miscellaneous | Office | 240 | 114 | $24.97 | $5,992 |
| 77080 Standard X-ray | Office | 219 | 219 | $38.71 | $8,478 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 200 | 40 | $4.19 | $839 |
| 83036 Blood Count | Office | 187 | 131 | $9.47 | $1,771 |
| 80048 Clinical Chemistry | Office | 154 | 143 | $8.29 | $1,277 |
| 99213 Office E&M - Established | Office | 127 | 117 | $63.77 | $8,098 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 86 | 76 | $12.60 | $1,084 |
| 84443 Clinical Chemistry | Office | 78 | 63 | $16.46 | $1,284 |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 74 | 26 | $32.14 | $2,379 |
| 96372 Injection Administration | Office | 71 | 39 | $10.80 | $767 |
| 83735 Clinical Chemistry | Office | 61 | 58 | $6.57 | $401 |
| 83880 Clinical Chemistry | Office | 60 | 58 | $38.47 | $2,308 |
By year: 2022 $180K for 11,042 services; 2023 $154K for 7,215 services; 2024 $190K for 9,933 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 433 | 350 | $8.61 | $3,728 |
| 83036 Blood Count | 187 | 131 | $9.47 | $1,771 |
| 80048 Clinical Chemistry | 154 | 143 | $8.29 | $1,277 |
| 84443 Clinical Chemistry | 78 | 63 | $16.46 | $1,284 |
| 83735 Clinical Chemistry | 61 | 58 | $6.57 | $401 |
| 83880 Clinical Chemistry | 60 | 58 | $38.47 | $2,308 |
| 80061 Clinical Chemistry | 49 | 48 | $13.12 | $643 |
| 82043 Clinical Chemistry | 48 | 46 | $5.54 | $266 |
| 82565 Clinical Chemistry | 40 | 40 | $5.02 | $201 |
| 82306 Clinical Chemistry | 36 | 34 | $29.01 | $1,044 |
Medicare prescription drug claims, 2024
In 2024, the drug Luke E Benedict prescribed most often to Medicare patients was Levothyroxine Sodium, with 627 prescriptions and refills. In total Luke E Benedict wrote 6,659 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 627 | 1,735 | 168 | $11K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 332 | 797 | 108 | $62K |
| Ozempic Semaglutide | 320 | 541 | 76 | $509K |
| Metformin Hcl Generic | 292 | 801 | 77 | $3,751 |
| Atorvastatin Calcium Generic | 269 | 790 | 82 | $2,753 |
| Jardiance Empagliflozin | 215 | 523 | 53 | $300K |
| Metformin Hcl Er Metformin Hcl | 201 | 565 | 62 | $3,261 |
| Glipizide Er Glipizide | 180 | 500 | 51 | $3,208 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 148 | 327 | 34 | $208K |
| Humalog Kwikpen U-100 Insulin Lispro | 141 | 350 | 50 | $52K |
| Mounjaro Tirzepatide | 123 | 180 | 34 | $189K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 112 | 315 | 55 | $16K |
| Norditropin Flexpro Somatropin | 110 | 111 | 12 | $211K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 102 | 235 | 36 | $57K |
| Synthroid Levothyroxine Sodium | 99 | 259 | 21 | $9,066 |
Brand drugs: 2,973 claims; generic drugs: 3,141 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luke E Benedict $25.36 ($25.36 in general payments such as food, travel and fees) from 1 company. The largest payer was Tandem Diabetes Care, Inc. with $25.36.
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. TNDM | 1 | $25.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.